| 1. Shi K, Zou M, Jia DM, Shi S, Yang X, Liu Q, Dong JF, Sheth KN, Wang X, Shi FD*.tPA Mobilizes Immune Cells That Exacerbate Hemorrhagic Transformation in Stroke..Circ Res.2021.128(1).62-75.SCI |
| 2. Li Z#, Li Y, Han J, Zhu Z, Li M, Liu Q, Wang Y, Shi FD*.Formyl peptide receptor 1 signaling potentiates inflammatory brain injury.Sci Transl Med.2021.13(605).eabe9890.SCI |
| 3. Jin WN, Shi K, He W, Sun JH, Van Kaer L, Shi FD, Liu Q*.Neuroblast senescence in the aged brain augments natural killer cell cytotoxicity leading to impaired neurogenesis and cognition.Nat Neurosci.2021.24(1).61-73.SCI |
| 4. Zhang C, Bu B, Yang H, Wang L, Liu W, Duan RS, Zhang M, Zeng P, Du C, Yang L, Shi FD*.Immunotherapy choice and maintenance for generalized myasthenia gravis in China..CNS Neurosci Ther.2020.26(12).1241-1254.SCI |
| 5. Fan M, Qiu W, Bu B, Xu Y, Yang H, Huang D, Lau AY, Guo J, Zhang MN, Zhang X, Yang CS, Chen J, Zheng P, Liu Q, Zhang C, Shi FD*.Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders..Neurol Neuroimmunol Neuroinflamm.2020.7(5).e787.SCI |
| 6. Zhang C, Zhang M, Qiu W, Ma H, Zhang X, Zhu Z, Yang CS, Jia D, Zhang TX, Yuan M, Feng Y, Yang L, Lu W, Yu C, Bennett JL, Shi FD*.Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial..Lancet Neurol.2020.19(5).391-401.SCI |
| 7. Shi K, Tian DC, Li ZG, Ducruet AF, Lawton MT, Shi FD*..Global brain inflammation in stroke.The Lancet. Neurology.2019.18（11）.1058-1066.SCI |
| 8. Yang CS, Zhang QX, Deng Y, Zhou BJ, Zhang LJ, Li LM, Qi Y, Wang J, Yang L, Shi FD*.Increased serum IL-36β and IL-36γ levels in patients with neuromyelitis optica spectrum disorders: association with disease activity.BMC neurology.2019.19(1).1471-2377.SCI |
| 9. Liu Q, Shi FD*.Enhancing natural killer cells is beneficial in multiple sclerosis - No.Multiple sclerosis .2019.25(4).512-513.SCI |
| 10. Zhao H, Feng Y, Wei C, Li Y, Ma H, Wang X, Cui Z, Jin WN, Shi FD*..Colivelin Rescues Ischemic Neuron and Axons Involving JAK/STAT3 Signaling Pathway.Neuroscience.2019.416.198-206.SCI |
| 11. Shi K, Zhang J, Dong JF, Shi FD*.Dissemination of brain inflammation in traumatic brain injury.Cellular & molecular immunology.2019.16(6).523-530.SCI |
| 12. Yang CS, Zhang LJ, Sun ZH, Yang L, Shi FD*.Acute prevertebral abscess secondary to intradiscal oxygen-ozone chemonucleolysis for treatment of a cervical disc herniation.J Int Med Res.2018.0（0）.1-5.SCI |
| 13. Yang CS, Zhang QX, Chang SH, Zhang LJ, Li LM, Qi Y, Wang J, Sun ZH, Zhangning N, Yang L, Shi FD*.Neuromyelitis optica spectrum disorders with and without connective tissue disorders.BMC neurology.2018.18(1).177.SCI |
| 14. Yao Y, Miao W, Liu Z, Han W, Shi K, Shen Y, Li H, Liu Q, Fu Y, Huang D, Shi FD*.Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice.Translational stroke research.2018.7(6).535-547.SCI |
| 15. Tian DC, Shi K, Zhu Z, Yao J, Yang X, Su L, Zhang S, Zhang M, Gonzales RJ, Liu Q, Huang D, Waters MF, Sheth KN, Ducruet AF, Fu Y, Lou M, Shi FD*. .Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow.Ann Neurol.2018.84（5）.717-728.SCI |
| 16. Jin WN, Ducruet AF, Liu Q, Shi SX, Waters M, Zou M, Sheth KN, Gonzales R, Shi FD*.Activation of JAK/STAT3 restores NK-cell function and improves immune defense after brain ischemia.FASEB J.2018.32(5).2757-2767.SCI |
| 17. Li M, Li Z, Yao Y, Jin WN, Wood K, Liu Q, Shi FD, Hao J*.Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity.Proceedings of the National Academy of Sciences of the United States of America.2017.114(3).E396-E405.SCI |
| 18. Liu Q, Jin WN, Liu Y, Shi K, Sun H, Zhang F, Zhang C, Gonzales RJ, Sheth KN, La Cava A, Shi FD*.Brain ischemia suppresses immunity in the periphery and brain via different neurogenic innervations.Immunity.2017.46（3）.474-487.SCI |
| 19. Fan M, Fu Y, Su L, Shen Y, Wood K, Yang L, Liu Y, Shi FD*..Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody.Multiple Sclerosis and Related Disorders.2017.13（0）.58-66.SCI |
| 20. De-cai Tian, Lei Su, Moli Fan, Jian Yang, Rui Zhang, Peng Wen, Yujuan Han, Changlu Yu, Chao Zhang, Honglei Ren, Kaibin Shi, Zilong Zhu, Yinhua Dong, Yaou Liu, Fu-Dong Shi*.Bidirectional degeneration in the visual pathway in neuromyelitis optica spectrum disorder (NMOSD).Multiple sclerosis journal.2017.0（0）.1-9.SCI |
| 21. Li M, Li Z, Ren H, Jin WN, Wood K, Liu Q, Sheth KN, Shi FD*.Colony stimulating factor 1 receptor inhibition eliminates microglia and attenuates brain injury after intracerebral hemorrhage.Journal of cerebral blood flow and metabolism.2017.37（7）.2382-2395.SCI |
| 22. Zhang C, Tian DC, Yang CS, Han B, Wang J, Yang L, Shi FD*.Safety and Efficacy of Bortezomib in Patients With Highly Relapsing Neuromyelitis Optica Spectrum Disorder.JAMA Neurology.2017.74（8）.1010-1012.SCI |
| 23. Zhang J, Shi K, Li Z, Li M, Han Y, Wang L, Zhang Z, Yu C, Zhang F, Song L, Dong JF, La Cava A, Sheth KN, Shi FD*.Organ- and cell-specific immune responses are associated with the outcomes of intracerebral hemorrhage.FASEB journal.2017.32（1）.1-10.SCI |
| 24. Liu Q, Sanai N, Jin WN, La Cava A, Van Kaer L, Shi FD*.Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation.Nature Neuroscience.2016.19（2）.243-252.SCI |
| 25. Yan Y, Li Y, Fu Y, Yang L, Su L, Shi K, Li M, Liu Q, Borazanci A, Liu Y, He Y, Bennett JL, Vollmer TL, Shi FD*.Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD.SCIENCE CHINA-LIFE SCIENCES.2016.59（12）.1270-1281.SCI |
| 26. Sun N, Shen Y, Han W, Shi K, Wood K, Fu Y, Hao J, Liu Q, Sheth KN, Huang D, Shi FD*.Selective sphingosine-1-phosphate receptor 1 modulation attenuates experimental.Stroke.2016.47（7）.1899-1906.SCI |
| 27. Fu Y, Yan Y, Qi Y, Yang L, Li T, Zhang N, Yu C, Su L, Zhang R, Shen Y, Lin S, Liu Q, Shao Z, Han Z, Shi FD*.Impact of Autologous Mesenchymal Stem Cell Infusion on Neuromyelitis Optica Spectrum Disorder: A Pilot, 2-Year Observational Study.CNS Neuroscience & Therapeutics.2016.22（8）.677-685.SCI |
| 28. Fu Y, Liu Q, Anrather J, Shi FD*.Immune interventions in stroke.Nature Reviews Neurology.2015.11（9）.524-535.SCI |
| 29. Liu Y, Fu Y, Schoonheim MM, Zhang N, Fan M, Su L, Shen Y, Yan Y, Yang L, Wang Q, Zhang N, Yu C, Barkhof F, Shi FD*.Structural MRI substrates of cognitive impairment in neuromyelitis optica.Neurology.2015.85（17）.1491-1499.SCI |
| 30. Zhu Z, Fu Y, Tian D, Sun N, Han W, Chang G, Dong Y, Xu X, Liu Q, Huang D, Shi FD*.Combination of an immune modulator fingolimod with alteplase in acute ischemic stroke.Circulation.2015.132（12）.1104-1112.SCI |
| 31. Song Y, Pan L, Fu Y, Sun N, Li YJ, Cai H, Su L, Shen Y, Cui L, Shi FD*.Sleep abnormality in neuromyelitis optica spectrum disorder.Neurology(R) neuroimmunology & neuroinflammation.2015.2(3).e94.SCI |
| 32. Fu Y, Zhang N, Ren L, Yan Y, Sun N, Li YJ, Han W, Xue R, Liu Q, Hao J, Yu C, Shi FD*.Impact of an immune modulator fingolimod on acute ischemic stroke.Proceedings of the national academy of sciences of the united states of america.2014.111（51）.18315-18320.SCI |
| 33. Kong XD, Bai S, Chen X, Wei HJ, Jin WN, Li MS, Yan Y, Shi FD*.Alterations of natural killer cells in traumatic brain injury.Neuroscience Bulletin.2014.30（6）.903-912.SCI |
| 34. Su N, Shi SX, Zhu X, Borazanci A, Shi FD*, Gan Y*.Interleukin-7 expression and its effect on natural killer cells in patients with multiple sclerosis.Journal of neuroimmunology.2014.276（1-2）.180-186.SCI |
| 35. Fu Y, Hao J, Zhang N, Ren L, Sun N, Li YJ, Yan Y, Huang D, Yu C, Shi FD*.Fingolimod for the Treatment of Intracerebral Hemorrhage: A 2-Arm Proof-of-Concept Study.JAMA Neurology.2014.71（9）.1092-1101.SCI |
| 36. Gan Y, Liu Q, Wu W, Yin JX, Bai XF, Shen R, Wang Y, Chen J, La Cava A, Poursine-Laurent J, Yokoyama W, Shi FD*.Ischemic neurons recruit NK cells that accelerate brain infarction.Proceedings of the national academy of sciences of the united states of america.2014.111（7）.2704-2709.SCI |
| 37. Sun F, Ladha SS, Yang L, Liu Q, Shi SX, Su N, Bomprezzi R, Shi FD*.IL-10 producing B cells in myasthenia gravis during rituximab therapy.Muscle and Nerve.2014.49（4）.487-494.SCI |
| 38. Zhang CJ, Zhai H, Yan Y, Hao J, Li MS, Jin WN, Su N, Vollmer TL, Shi FD*.Glatiramer acetate ameliorates experimental autoimmune neuritis.immunology and cell biology.2014.92（2）.164-169.SCI |
| 39. Zhiwei Tang,Yan Gan,Qiang Liu,Jun-Xiang Yin,Qingwei Liu,Jiong Shi,Fu-Dong Shi*.CX3CR1 deficiency suppresses proliferation and neurotoxicity of macrophage/microglia in MCAO mice.Journal of Neuroinflammation.2014.11（0）.26.SCI |
| 40. Yang CS, Yang L, Li T, Zhang DQ, Jin WN, Li MS, Su N, Zhangning N, Liu Q, Shao ZH, Yu C, Shi FD*.Responsiveness to reduced dosage of rituximab in Chinese neuromyelitis optica patients.Neurology.2013.81（8）.710-713.SCI |
| 41. Simard AR, Gan Y, St-Pierre S, Kousari A, Patel V, Whiteaker P, Morley BJ, Lukas RJ, Shi FD*.Differential modulation of EAE by α9*- and β2*-nicotinic acetylcholine receptors.Immunology and Cell Biology.2013.91（3）.195-200.SCI |
